Pieris Pharmaceuticals, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
PIRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
225 Franklin Street, 26 Th Floor, Boston, MA

Insiders trading volume in the past year

Pieris Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Wes Kaupinen President and CEO, Director, 10%+ Owner $25.5M Dec 13, 2024
George M. Jenkins Director $2.48M +$51.7K +2.13% Dec 18, 2024
ADAR1 Capital Management, LLC 10%+ Owner $2.3M +$92.3K +4.19% Aug 9, 2024
Dellora Investments LP no longer 10% owner $2.24M Dec 13, 2024
Todd C. Davis Director $1.79M Dec 13, 2024
Elaine J. Heron Director $815K Dec 13, 2024
Bvf Partners L P/Il Other* $619K Dec 13, 2024
Tim Demuth Chief Medical Officer $5.1K May 13, 2022
James A. Geraghty Director $0 Dec 12, 2024
Kathleen Goin Chief Operating Officer Dec 13, 2024
Michael Richman Director Jun 21, 2023
Jeffrey S. Martini Chief Scientific Officer Dec 13, 2024
Matthew L. Sherman Director Jun 21, 2023
Ann Barbier Director Jun 21, 2023
Maya R. Said Director Jun 21, 2023
Shane Olwill Chief Development Officer Feb 24, 2023
Ahmed Mousa Chief Business Officer Feb 24, 2023
Christopher P. Kiritsy Director Dec 13, 2024
Stephen S. Yoder Chief Executive Officer, Director Feb 24, 2023
Hitto Kaufmann Chief Scientific Officer Feb 24, 2023
Thomas Bures Chief Financial Officer Feb 24, 2023
Tadd S. Wessel Director Dec 13, 2024
Peter Kiener Director Jun 21, 2023
Matthew E. Korenberg CFO, Treasurer Dec 13, 2024

Recent Insider Transactions by Companies or Individuals for Pieris Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.